Compare WMS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMS | GKOS |
|---|---|---|
| Founded | 1966 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 10.9B |
| IPO Year | 2014 | 2015 |
| Metric | WMS | GKOS |
|---|---|---|
| Price | $130.98 | $176.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $180.63 | $126.92 |
| AVG Volume (30 Days) | ★ 656.6K | 635.4K |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.19 | N/A |
| Revenue | ★ $3,050,376,000.00 | $507,442,000.00 |
| Revenue This Year | $5.23 | $23.32 |
| Revenue Next Year | $12.79 | $27.43 |
| P/E Ratio | $61.98 | ★ N/A |
| Revenue Growth | 5.03 | ★ 32.33 |
| 52 Week Low | $128.03 | $73.16 |
| 52 Week High | $179.32 | $191.62 |
| Indicator | WMS | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 34.25 | 52.02 |
| Support Level | $129.64 | $175.04 |
| Resistance Level | $155.66 | $184.00 |
| Average True Range (ATR) | 4.18 | 5.71 |
| MACD | -1.32 | -2.16 |
| Stochastic Oscillator | 0.93 | 14.84 |
Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.